12-25241845-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004985.5(KRAS):​c.111+3429G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.541 in 151,914 control chromosomes in the GnomAD database, including 23,247 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene KRAS is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.54 ( 23247 hom., cov: 31)

Consequence

KRAS
NM_004985.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.277

Publications

12 publications found
Variant links:
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
KRAS Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Noonan syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • linear nevus sebaceous syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome with multiple lentigines
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Noonan syndrome-like disorder with loose anagen hair
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004985.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KRAS
NM_033360.4
MANE Plus Clinical
c.111+3429G>A
intron
N/ANP_203524.1P01116-1
KRAS
NM_004985.5
MANE Select
c.111+3429G>A
intron
N/ANP_004976.2
KRAS
NM_001369786.1
c.111+3429G>A
intron
N/ANP_001356715.1P01116-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KRAS
ENST00000256078.10
TSL:1 MANE Plus Clinical
c.111+3429G>A
intron
N/AENSP00000256078.5P01116-1
KRAS
ENST00000311936.8
TSL:1 MANE Select
c.111+3429G>A
intron
N/AENSP00000308495.3P01116-2
KRAS
ENST00000556131.2
TSL:1
c.111+3429G>A
intron
N/AENSP00000451856.1G3V4K2

Frequencies

GnomAD3 genomes
AF:
0.541
AC:
82084
AN:
151796
Hom.:
23239
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.354
Gnomad AMI
AF:
0.504
Gnomad AMR
AF:
0.566
Gnomad ASJ
AF:
0.651
Gnomad EAS
AF:
0.798
Gnomad SAS
AF:
0.602
Gnomad FIN
AF:
0.567
Gnomad MID
AF:
0.544
Gnomad NFE
AF:
0.615
Gnomad OTH
AF:
0.567
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.541
AC:
82120
AN:
151914
Hom.:
23247
Cov.:
31
AF XY:
0.542
AC XY:
40257
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.354
AC:
14659
AN:
41432
American (AMR)
AF:
0.566
AC:
8643
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.651
AC:
2257
AN:
3468
East Asian (EAS)
AF:
0.798
AC:
4126
AN:
5172
South Asian (SAS)
AF:
0.601
AC:
2896
AN:
4816
European-Finnish (FIN)
AF:
0.567
AC:
5971
AN:
10524
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.615
AC:
41759
AN:
67930
Other (OTH)
AF:
0.568
AC:
1193
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1828
3655
5483
7310
9138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
710
1420
2130
2840
3550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.585
Hom.:
18669
Bravo
AF:
0.533
Asia WGS
AF:
0.668
AC:
2322
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.7
DANN
Benign
0.73
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12813551; hg19: chr12-25394779; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.